Good evening. Here is the latest roundup of deal flow in the Lone Star State:
GenrAb (Dallas, TX), a developer of neuroprotective therapies, raised $5.6 million of seed funding in a deal led by Actium with participation from Research Bridge Partners, Salem Partners and others. GenrAb has raised $6.05 million to date.
SmartAC (Houston, TX), a developer of …
Keep reading with a 7-day free trial
Subscribe to Texas CEO Magazine to keep reading this post and get 7 days of free access to the full post archives.